Endo Net Profit Margin 2006-2019 | ENDP

Endo net profit margin from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Endo Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-06-30 $2.95B $-0.59B -19.99%
2019-03-31 $2.97B $-0.55B -18.37%
2018-12-31 $2.95B $-1.03B -34.98%
2018-09-30 $2.93B $-1.11B -37.78%
2018-06-30 $2.97B $-1.03B -34.69%
2018-03-31 $3.13B $-2.37B -75.55%
2017-12-31 $3.47B $-2.04B -58.67%
2017-09-30 $3.94B $-5.01B -126.96%
2017-06-30 $4.04B $-5.13B -126.93%
2017-03-31 $4.09B $-3.39B -82.91%
2016-12-31 $4.01B $-3.35B -83.45%
2016-09-30 $3.84B $-0.13B -3.30%
2016-06-30 $3.71B $-0.96B -25.86%
2016-03-31 $3.52B $-1.55B -44.10%
2015-12-31 $3.27B $-1.49B -45.70%
2015-09-30 $2.86B $-1.43B -50.00%
2015-06-30 $2.77B $-0.63B -22.81%
2015-03-31 $2.62B $-0.36B -13.72%
2014-12-31 $2.38B $-0.72B -30.28%
2014-09-30 $1.81B $-1.44B -79.73%
2014-06-30 $1.82B $-1.15B -63.37%
2014-03-31 $1.94B $-1.14B -58.75%
2013-12-31 $2.12B $-0.69B -32.30%
2013-09-30 $2.62B $-0.63B -23.89%
2013-06-30 $2.71B $-0.61B -22.59%
2013-03-31 $2.78B $-0.64B -22.93%
2012-12-31 $2.82B $-0.74B -26.29%
2012-09-30 $2.82B $0.01B 0.46%
2012-06-30 $2.83B $0.00B 0.00%
2012-03-31 $2.66B $0.05B 1.73%
2011-12-31 $2.53B $0.19B 7.49%
2011-09-30 $2.44B $0.25B 10.05%
2011-06-30 $2.12B $0.26B 12.15%
2011-03-31 $1.91B $0.25B 13.28%
2010-12-31 $1.72B $0.26B 15.03%
2010-09-30 $1.60B $0.31B 19.61%
2010-06-30 $1.51B $0.31B 20.36%
2010-03-31 $1.49B $0.29B 19.27%
2009-12-31 $1.46B $0.27B 18.22%
2009-09-30 $1.42B $0.19B 13.49%
2009-06-30 $1.37B $0.21B 15.16%
2009-03-31 $1.31B $0.24B 18.01%
2008-12-31 $1.26B $0.26B 20.32%
2008-09-30 $1.22B $0.23B 19.21%
2008-06-30 $1.17B $0.23B 19.40%
2008-03-31 $1.12B $0.23B 20.61%
2007-12-31 $1.09B $0.23B 21.01%
2007-09-30 $1.04B $0.19B 18.48%
2007-06-30 $0.99B $0.18B 18.03%
2007-03-31 $0.96B $0.18B 18.27%
2006-12-31 $0.91B $0.14B 15.29%
2006-09-30 $0.89B $0.20B 22.11%
2006-06-30 $0.92B $0.22B 23.83%
2006-03-31 $0.89B $0.21B 23.68%
2005-12-31 $0.82B $0.20B 24.76%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.874B $2.947B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.854B 36.25
Astellas Pharma (ALPMY) Japan $27.542B 13.12
Takeda Pharmaceutical (TAK) Japan $26.873B 8.39
UCB SA (UCBJF) Belgium $14.267B 0.00
Merck (MKGAF) Germany $14.152B 19.31
Eisai (ESALY) Japan $14.058B 24.17
Grifols, S.A (GRFS) Spain $14.054B 17.93
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.261B 0.00
Ionis Pharmaceuticals (IONS) United States $8.867B 19.12
IPSEN SA ADR (IPSEY) France $8.529B 0.00
Sage Therapeutics (SAGE) United States $8.290B 0.00
Catalent (CTLT) United States $7.406B 29.32
Jazz Pharmaceuticals (JAZZ) Ireland $7.388B 9.72
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.022B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.044B 18.13
United Therapeutics (UTHR) United States $3.692B 0.00
FibroGen (FGEN) United States $3.560B 89.04
Nektar Therapeutics (NKTR) United States $3.523B 0.00
Evotec AG (EVTCY) Germany $3.399B 46.53
Taro Pharmaceutical Industries (TARO) Israel $3.150B 11.29
Tilray (TLRY) Canada $2.976B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.776B 63.65
PTC Therapeutics (PTCT) United States $2.270B 0.00
Portola Pharmaceuticals (PTLA) United States $2.059B 0.00
Xencor (XNCR) United States $2.037B 44.42
Zogenix (ZGNX) United States $1.840B 0.00
Heron Therapeutics (HRTX) United States $1.676B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.553B 15.57
Corcept Therapeutics (CORT) United States $1.548B 21.28
Pacira Pharmaceuticals (PCRX) United States $1.547B 56.30
Ironwood Pharmaceuticals (IRWD) United States $1.505B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.391B 22.95
Radius Health (RDUS) United States $1.320B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.283B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.052B 0.00
Aerie Pharmaceuticals (AERI) United States $0.994B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.975B 4.35
ArQule (ARQL) United States $0.957B 0.00
TherapeuticsMD (TXMD) United States $0.929B 0.00
Karyopharm Therapeutics (KPTI) United States $0.725B 0.00
Concordia (CXRXF) Canada $0.681B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.674B 0.00
Lannett Co Inc (LCI) United States $0.566B 5.96
Flexion Therapeutics (FLXN) United States $0.554B 0.00
Akebia Therapeutics (AKBA) United States $0.548B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.544B 0.00
Organogenesis Holdings (ORGO) United States $0.542B 0.00
Translate Bio (TBIO) United States $0.511B 0.00
Aptorum Group (APM) China $0.488B 0.00
ImmunoGen (IMGN) United States $0.472B 0.00
Siga Technologies (SIGA) United States $0.462B 1.08
Innate Pharma SA (IPHYF) France $0.455B 0.00
Indivior (INVVY) United States $0.453B 1.64
Dova Pharmaceuticals (DOVA) United States $0.446B 0.00
Dermira (DERM) United States $0.438B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.428B 19.47
ChemoCentryx (CCXI) United States $0.421B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.416B 0.00
Collegium Pharmaceutical (COLL) United States $0.392B 0.00
DURECT (DRRX) United States $0.372B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.362B 0.00
Harpoon Therapeutics (HARP) United States $0.348B 0.00
OptiNose (OPTN) United States $0.335B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.311B 0.00
Ardelyx (ARDX) United States $0.306B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.293B 0.00
CV Sciences (CVSI) United States $0.289B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.285B 0.00
Rafael Holdings (RFL) United States $0.283B 0.00
Xeris Pharmaceuticals (XERS) United States $0.279B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.274B 0.00
Recro Pharma (REPH) United States $0.263B 0.00
Concert Pharmaceuticals (CNCE) United States $0.262B 0.00
KalVista Pharmaceuticals (KALV) United States $0.258B 0.00
Molecular Templates (MTEM) United States $0.229B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.216B 0.00
Calithera Biosciences (CALA) United States $0.213B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.211B 0.00
Ocular Therapeutix (OCUL) United States $0.203B 0.00
GlycoMimetics (GLYC) United States $0.196B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 31.55
CannTrust Holdings (CTST) Canada $0.180B 0.00
Generex Biotechnology (GNBT) United States $0.176B 0.00
Redhill Biopharma (RDHL) Israel $0.167B 0.00
IMV INC (IMV) Canada $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
MEI Pharma (MEIP) United States $0.143B 0.00
ElectroCore (ECOR) United States $0.141B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.133B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.124B 0.00
Cardiome Pharma (CORV) Canada $0.123B 0.00
Jounce Therapeutics (JNCE) United States $0.113B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Majesco Entertainment (PTE) United States $0.108B 0.00
Mast Therapeutics (SVRA) United States $0.104B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.104B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.099B 0.00
Genocea Biosciences (GNCA) United States $0.094B 0.00
AgeX Therapeutics (AGE) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.090B 0.00
Iterum Therapeutics (ITRM) Ireland $0.089B 0.00
Aquestive Therapeutics (AQST) United States $0.087B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
RENEURON GP (RNUGF) United Kingdom $0.084B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Nivalis Therapeutics (ALPN) United States $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.077B 29.53
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Natural Alternatives (NAII) United States $0.074B 7.39
Lipocine (LPCN) United States $0.073B 0.00
Novan (NOVN) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.071B 0.00
Jaguar Animal Health (JAGX) United States $0.068B 0.00
Aclaris Therapeutics (ACRS) United States $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Otonomy (OTIC) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.064B 0.00
China SXT Pharmaceuticals (SXTC) China $0.059B 0.00
Capnia (SLNO) United States $0.058B 0.00
CTI BioPharma (CTIC) United States $0.050B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.048B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 1.62
Adamis Pharmaceuticals (ADMP) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Melinta Therapeutics (MLNT) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Opexa Therapeutics (ACER) United States $0.035B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.032B 0.00
Biomerica (BMRA) United States $0.031B 0.00
IsoRay (ISR) United States $0.025B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.020B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Vical (BBI) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Onconova Therapeutics (ONTX) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00